The global blood bags market size is anticipated to reach USD 526.82 million by 2030, registering a CAGR of 7.50% from 2025 to 2030, according to a new report by Grand View Research, Inc. The market forms a critical segment of the global medical devices and healthcare consumables industry, underpinned by its indispensable role in transfusion medicine and emergency care. Blood bags, primarily composed of medical-grade PVC and other biocompatible polymers, are engineered to collect, store, transport, and separate blood and its components efficiently. These bags are extensively utilized across hospitals, blood banks, and diagnostic centers for applications ranging from trauma response and surgical interventions to chronic disease management. Their reliability, sterility, and compatibility with blood preservation protocols make them a foundational product in both advanced and developing healthcare systems.
A primary driver propelling the market is the rising global volume of surgical procedures and medical emergencies that necessitate blood transfusions. Compared to traditional glass containers, modern blood bags offer enhanced safety, better storage flexibility, and easier handling. The ability to separate blood into its components—red cells, plasma, and platelets—using multi-chamber bags enables more targeted therapies and efficient resource utilization. Furthermore, innovation in blood bag technology, such as integration with RFID tracking systems and the development of pathogen-reduction compatible designs, is elevating product utility and compliance with stringent healthcare standards. These advancements continue to strengthen the market's relevance across both high-income and emerging economies.
The market players are focusing on various strategic initiatives such as mergers, acquisitions, and collaborations. For instance, in June 2024, WEGO Medical, a subsidiary of the Weigao Group, participated in the 14th Blood Transfusion Organization Conference in Indonesia, where it showcased its blood bank solutions, including blood bags, blood collection tubes, and transfusion sets.
Request a free sample copy or view report summary: Blood Bags Market Report
Based on product, single blood bags dominated the industry, accounting for a market share of 39.88% in 2024.
Based on application, collection blood bags accounted for the largest share of 61.23% in 2024.
Based on end use, hospitals & clinics accounted for the largest share of 48.61% in 2024.
Grand View Research has segmented the blood bags market based on product, application, end use, and region:
Blood Bags Product Outlook (Revenue, USD Million, 2018 - 2030)
Single Blood Bag
Double Blood Bag
Triple Blood Bag
Others
Blood Bags Application Outlook (Revenue, USD Million, 2018 - 2030)
Collection Blood Bags
Transfer Blood Bags
Blood Bags End Use Outlook (Revenue, USD Million, 2018 - 2030)
Hospitals & Clinics
Blood Banks
Others
Blood Bags Regional Outlook (Revenue, USD Million, 2018 - 2030)
North America
U.S.
Canada
Mexico
Europe
Germany
UK
France
Italy
Spain
Asia Pacific
China
India
Japan
South Korea
Australia
Central & South America
Brazil
Argentina
Middle East & Africa
Saudi Arabia
South Africa
UAE
List of Key Players in the Blood Bags Market
TERUMO BCT, INC.
Macopharma
Fresenius Kabi India Pvt. Ltd
Grifols, S.A.
Neomedic International SL
Teleflex Incorporated
Qingdao Sinoland International Trade Co., Ltd
JMS Co.Ltd
Demophorius Healthcare Ltd
KAWASUMI LABORATORIES. INC.
Polymedicure
AdvaCare Pharma
Coloplast Corp
"The quality of research they have done for us has been excellent..."